Drug intelligence / Profile preview

DIFTETALL

Development stage
Unknown
Lead developer
ASTRO
Modality
Vaccines & Immunotherapeutics
Administration
Intramuscular
01

Overview

DIFTETALL is a bivalent vaccine containing adsorbed diphtheria and tetanus toxoids, specifically formulated with a reduced antigen content (Td) for use in adults and adolescents. Developed and marketed by ASTRO Pharma, it is authorized in Italy as an injectable suspension in pre-filled syringes. The vaccine works by stimulating the immune system to produce specific antitoxins that neutralize the toxins produced by *Corynebacterium diphtheriae* and *Clostridium tetani*, thereby providing active immunization against diphtheria and tetanus. It is primarily used for booster vaccinations or as part of a primary immunization schedule where a reduced diphtheria component is indicated.

Brand names
DIFTETALL
Other names
tetanus and diphtheria toxoids vaccineTd vaccinediphtheria and tetanus toxoids (adsorbed) vaccine
02

Targets

Diphtheria toxin

Beyond the preview

Go deeper on DIFTETALL.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DIFTETALL.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call